BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25758980)

  • 1. Paraoxon and Pyridostigmine Interfere with Neural Stem Cell Differentiation.
    Berríos VO; Boukli NM; Rodriguez JW; Negraes PD; Schwindt TT; Trujillo CA; Oliveira SL; Cubano LA; Ferchmin PA; Eterović VA; Ulrich H; Martins AH
    Neurochem Res; 2015 Oct; 40(10):2091-101. PubMed ID: 25758980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation-dependent effects of chlorpyrifos and parathion and their oxygen analogs on acetylcholinesterase and neuronal and glial markers in aggregating brain cell cultures.
    Monnet-Tschudi F; Zurich MG; Schilter B; Costa LG; Honegger P
    Toxicol Appl Pharmacol; 2000 Jun; 165(3):175-83. PubMed ID: 10873710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of cell death and the role of acetylcholinesterase activity in neurotoxicity induced by paraoxon in cultured rat hippocampal neurons.
    Bahrami F; Yousefpour M; Mehrani H; Golmanesh L; Sadraee SH; Khoshbaten A; Asgari A
    Acta Biol Hung; 2009 Mar; 60(1):1-13. PubMed ID: 19378919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
    Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
    Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
    Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with pyridostigmine bromide has no effect on seizure behavior or 24 hour survival in the rat model of acute diisopropylfluorophosphate intoxication.
    Bruun DA; Guignet M; Harvey DJ; Lein PJ
    Neurotoxicology; 2019 Jul; 73():81-84. PubMed ID: 30853371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
    Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
    J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning.
    Lenina OA; Zueva IV; Zobov VV; Semenov VE; Masson P; Petrov KA
    Sci Rep; 2020 Oct; 10(1):16611. PubMed ID: 33024231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides.
    Henderson JD; Glucksman G; Leong B; Tigyi A; Ankirskaia A; Siddique I; Lam H; DePeters E; Wilson BW
    J Biochem Mol Toxicol; 2012 Jan; 26(1):31-4. PubMed ID: 21972196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats.
    Shaikh J; Pope CN
    Toxicology; 2003 Aug; 190(3):221-30. PubMed ID: 12927376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of organophosphates on cholinesterase activity and neurite regeneration in Aplysia.
    Srivatsan M
    Chem Biol Interact; 1999 May; 119-120():371-8. PubMed ID: 10421473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
    Milatovic D; Dettbarn WD
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.
    Song X; Pope C; Murthy R; Shaikh J; Lal B; Bressler JP
    Toxicol Sci; 2004 Apr; 78(2):241-7. PubMed ID: 14976354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity.
    Tonduli LS; Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():426-7. PubMed ID: 16429574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.